Displaying 321 - 340 of 2128
In the Suleiman lab, we focus on studying the podocyte biology, specifically the actin dynamics and cytoskeleton. Our research includes examining the balance of Rac and RhoA, two members of the Rho small GTPases, in both healthy and diseased kidneys.
Our lab focuses on developing methods, platforms, and infrastructure for the integration and analysis of multimodal healthcare and biomedical data to address important clinical questions.
Enter a description of the lab. This information will appear on the lab listing page.
The Kohler research group is committed to developing and implementing new tools optimized for the study of glycosylated molecules.
Dr. Rajji focuses on improving cognition in older adults with or at risk for dementia through brain stimulation, with cognitive, functional, and pharmacological modalities.
We employ a variety of methods including evolutionary analysis, genomics, and molecular biology to study the biology of infection.
The Lee Lab is dedicated to leveraging human and molecular genetics to explore the complex interactions between cells and the surrounding extracellular matrix, with a particular focus on cardiovascular development and disease.
The Callaway Lab studies how disruptions to lung development can predispose to long-term pathology.
We use neuroimaging, neuromodulation, and behavioral experimentation to elucidate the brain circuits and mechanisms that support language and cognition, and to understand how these circuits differ in neurodevelopmental conditions such as autism. We are particularly interested in the role of cerebro-cerebellar circuits in language and cognition across development and disorders.
Our mission is to advance biomedical knowledge in Multiple Sclerosis and support investigators in Neurology using best practices and comprehensive biostatistics expertise.
The Norgard Laboratory is engaged in three areas of infectious disease research: syphilis, Lyme disease, and tularemia.
Our mission is to design and develop original devices, software solutions, and combined unique methodologies that translate into discoveries for next generation care.
We are interested in understanding the deregulation of epigenetic and transcriptional pathways in human disease and in finding small molecules with therapeutic potential to normalize these gene expression patterns.
Our work advocates for the wider adoption of alteplase, antiplatelet therapy in ischemic stroke, secondary stroke prevention, off-label guidelines for those with acute ischemic stroke, and more.
The Neuro-Oncology Translational Research Laboratory studies primary brain tumors from pure basic science through the continuum to clinical trials.
Leveraging cutting-edge genetic and chemical screens to uncover novel and enhanced therapeutics for cancer treatment.
The Molecular Imaging and Precision Medicine Lab has four Technology Research and Development (TR&D) projects that provide a platform on which new technology is developed and disseminated. The TR&Ds are complementary and integrated and extend from the development of reagents to detect and promote an immune reactive tumor microenvironment to the synthesis of nanodrones to treat cancer and combined small-molecule diagnostic and therapeutics (theranostic agents). We focus on generation of next-generation precision platforms, tools and techniques for tackling problems at the forefront of biomedical research with a focus on those that will lead to near-term translation.
Research lab led by Connie Hsia, M.D., in the Biomedical Engineering Graduate Program of UT Southwestern Medical School.
The goal of the Choi Lab is to develop novel immunotherapies. To accomplish this, we first utilize high-dimensional approaches on human disease samples. This approach identifies targetable disease-promoting molecular defects in immune cells. Then, we utilize engineering approaches ot reverse the molecular changes.
Dr. Noh's research specializes in deducing causal inference for time series microscopy images and developing statistical methods for genomic data analysis. Currently, he collaborates with peers in the Green Center for Systems Biology and in the Lyda Hill Department of Bioinformatics to develop statistical methods to resolve complex biomedical data.
